FDA Targets 7-OH Kratom Products in Crackdown on Unapproved Opioid-Like Supplements
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has issued warning letters to seven companies accused of unlawfully marketing products containing 7-hydroxymitragynine (7-OH), a potent opioid compound derived …
FDA Targets 7-OH Kratom Products in Crackdown on Unapproved Opioid-Like Supplements Read More